Overview:

Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus that causes respiratory infections such as pneumonia, bronchiolitis and among others. In tropical climates, RSV infection is more prominent during the rainy season. RSV infections cause a considerable burden on the global economy due to the high infection rate. According to the Centers for Disease Control and Prevention, an approximate of 150,000 hospitalizations (on average) are a result of RSV infections each year in the United States. The high incidence of the RSV infection, and unmet need for specific, rapid, and sensitive diagnostic techniques are the prime factors accounting for the RSV diagnostics market growth. 

The global RSV diagnostics market is categorized based on the diagnostic technologies, end-users, and geography. Based on the diagnostic technology types, the global market is segmented into molecular diagnostics, immunoassays, monoclonal antibodies, flow cytometry, diagnostic imaging, chromatography, gel microdroplets, and other technologies. Among these, molecular diagnostics have higher specificity and sensitivity that accounts for the higher preference. Thus, in 2017, the molecular diagnostics segment dominated the global RSV diagnostics market. Based on end-users, the global market is dominated by hospitals segmented owing to the high patient visits with RSV infection. However, the commercial health laboratories have gained attention in last few years and expected to be one of the fastest growing segment during the forecast period.

North America dominated the global RSV diagnostics market in 2017 owing to the rising patient pool with RSV infections and technological advancements in point-of-care molecular diagnostic devices. According to the data published by the Centers for Disease Control and Prevention (CDC), around 50,000 deaths were reported in 2012 due to pneumonia in the United States. Furthermore, Asia Pacific is identified to surge at fastest rate during the forecast period. High prevalence of bronchitis and pneumonia in this region accounted for the fastest growth during the forecast period.

Key market players hold the major market share and the rest of the market is occupied by the local players. The key players adopted certain organic and inorganic strategies to penetrate into the market. For instance, Abbott received US FDA clearance and CLIA waiver for its Alere Reader Lateral Flow Assay Analyzer and Alere i RSV Rapid Molecular Test in 2016. Furthermore, after the establishment of Abbott diagnostics division in India (2016), the company acquired Alere Medical (U.S.) in 2017. Such strategies are further adopted by other key players accounting for market growth.

The Global RSV Diagnostics Market is segmented on the following bases:

• Global RSV Diagnostics Market, by Diagnostic Technology, 2016-2026 (US$ Mn)
  • Molecular Diagnostics
  • Immunoassays
  • Monoclonal Antibodies
  • Flow Cytometry
  • Diagnostic Imaging
  • Chromatography
  • Gel Microdroplets
  • Other Technologies (Differential Light Scattering, Liposomes etc.)
• Global RSV Diagnostics Market, by End-users, 2016-2026 (US$ Mn)
  • Hospitals
  • Nursing Homes
  • Commercial Laboratories
  • Public Health Laboratories
• Global RSV Diagnostics Market, by Geography, 2016-2026 (US$ Mn)
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Rest of Middle East & Africa

Key Players Identified in RSV Diagnostics Market include:

Abbott Laboratories, Inc.,  bioMerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., EMD Millipore, and Thermo Fisher Scientific, Inc..

This report offers:

• The prominent end-users for RSV diagnostic kits across geographies
• The regional market comparison for RSV diagnostics and the most attractive region for expanding geographical outreach or product launch
• The current trends in RSV diagnostics market at the granular level
• Market sizing of the global RSV diagnostics market for the span of 10 years from 2016 to 2026 and quantification of market growth during the forecast period
• Mapping of the players based on the product offering, business strengths, strategic initiatives, product launches, geographical expansion and profiling of major players